Biogen

Biogen have over the years established several fruitful scientific collaborative projects at the global, regional and local level with the Karolinska Institute (KI).

During 2018 it was recognized by both Biogen and KI that both parties wanted to build a structured and long-term commitment towards working together in the field of multiple sclerosis ("MS") and other neurodegenerative diseases.

To this end a Master Research Collaboration Agreement (MRCA) was negotiated and signed in September 2018. The purposes of this MRCA were to reach agreement on overall terms and conditions for future joint projects, as well as to create an overall governance structure for overseeing ongoing projects and identifying new opportunities.

This MCA is governed by a Joint Advisory Committee (JAC) with equal representation from Biogen and KI.

JAC Member

Karolinska Institutet

.
Photo:

Jan Hillert

Professor and Senior Physician in Clinical Neuroscience.

Photo:

Miia Kivipelto 

Professor in Clinical Geriatrics (KI) and Senior Geriatrician and Director for Research & Development of Theme Aging at Karolinska University Hospital.

Photo:

Richard Cowburn 

Responsible Corporate Partnering, Head External Engagement Office.

Photo:

Biogen

Robert Hyde

Senior Director, Global Research Collaboration Lead, Global Medical

Photo:

Christina Gip

Head of Medical Sweden

Photo:

Sven Erickson

Sr Medical Manager AD

Projects ongoing

Projects completed

 

Contact details

Karolinska Institutet: Richard.Cowburn@ki.se

Biogen: Pernilla Iwanczyk, Medical Strategy & Execution Lead pernilla.iwanczyk@biogen.com